DE60216570D1 - METHOD FOR DETECTING ALZHEIMER DISEASE - Google Patents

METHOD FOR DETECTING ALZHEIMER DISEASE

Info

Publication number
DE60216570D1
DE60216570D1 DE60216570T DE60216570T DE60216570D1 DE 60216570 D1 DE60216570 D1 DE 60216570D1 DE 60216570 T DE60216570 T DE 60216570T DE 60216570 T DE60216570 T DE 60216570T DE 60216570 D1 DE60216570 D1 DE 60216570D1
Authority
DE
Germany
Prior art keywords
alzheimer disease
detecting alzheimer
disease
alzheimer
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216570T
Other languages
German (de)
Other versions
DE60216570T2 (en
Inventor
Zsuzsanna Nagy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of DE60216570D1 publication Critical patent/DE60216570D1/en
Application granted granted Critical
Publication of DE60216570T2 publication Critical patent/DE60216570T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/99—Isomerases (5.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Abstract

The present invention relates diagnostic screens for Alzheimer's disease, and in particular to diagnostic tests based on screening for the presence of cellular changes that occur early in the pathology of Alzheimer's disease.
DE60216570T 2001-03-12 2002-03-12 METHOD FOR DETECTING ALZHEIMER DISEASE Expired - Lifetime DE60216570T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0106051 2001-03-12
GBGB0106051.6A GB0106051D0 (en) 2001-03-12 2001-03-12 Diagnostic screens for alzheimer's disease
PCT/GB2002/001137 WO2002073212A2 (en) 2001-03-12 2002-03-12 Diagnostic screens for alzheimer's disease

Publications (2)

Publication Number Publication Date
DE60216570D1 true DE60216570D1 (en) 2007-01-18
DE60216570T2 DE60216570T2 (en) 2007-04-05

Family

ID=9910482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216570T Expired - Lifetime DE60216570T2 (en) 2001-03-12 2002-03-12 METHOD FOR DETECTING ALZHEIMER DISEASE

Country Status (9)

Country Link
US (1) US20040132113A1 (en)
EP (2) EP1724588B1 (en)
JP (3) JP4430306B2 (en)
AT (1) ATE347698T1 (en)
AU (1) AU2002238766A1 (en)
DE (1) DE60216570T2 (en)
ES (1) ES2272673T3 (en)
GB (1) GB0106051D0 (en)
WO (1) WO2002073212A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
GB0311835D0 (en) * 2003-05-22 2003-06-25 Isis Innovation Susceptibility gene for alzheimer's disease
ES2330465T3 (en) * 2006-02-03 2009-12-10 Mtm Laboratories Ag PROCEDURE TO PERFORM A DENATURING IMMUNO TEST.
WO2010112034A2 (en) * 2009-04-02 2010-10-07 Aarhus Universitet Compositions and methods for treatment and diagnosis of synucleinopathies
GB0912394D0 (en) * 2009-07-16 2009-08-26 Univ Birmingham Screening methods
GB201112246D0 (en) * 2011-07-15 2011-08-31 Univ Birmingham Diagnosis of alzheimer's disease
GB201212334D0 (en) 2012-07-11 2012-08-22 Warwick The Therapeutic targets for alzheimers disease
CN103808917B (en) * 2014-03-16 2015-11-04 国家烟草质量监督检验中心 A kind of tobacco juice for electronic smoke cell proliferation toxicity assessment method
CN103808919B (en) * 2014-03-16 2015-11-18 国家烟草质量监督检验中心 A kind of cigarette smoke propagation toxicity assessment method of mixing based on bromodeoxyuridine nucleosides
WO2019113277A1 (en) * 2017-12-08 2019-06-13 NeuroDiagnostics LLC Diagnosing disease via gene expression profile in synchronized cells
KR102478811B1 (en) 2020-08-21 2022-12-16 재단법인대구경북과학기술원 Novel biomarker composition for diagnosis of Alzheimer's Disease based on multiplex PCR platform

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4544993A (en) * 1992-06-24 1994-01-24 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
US5773219A (en) * 1992-10-06 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Process for detecting Alzheimer disease using cultured cells
US6022683A (en) * 1996-12-16 2000-02-08 Nova Molecular Inc. Methods for assessing the prognosis of a patient with a neurodegenerative disease
CA2222813A1 (en) * 1996-04-04 1997-10-16 University Of South Florida Variant presenilin-2 genes
US6342350B1 (en) * 1997-09-05 2002-01-29 The General Hospital Corporation Alpha-2-macroglobulin diagnostic test
WO2000079000A1 (en) * 1999-06-22 2000-12-28 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method for detection of early-onset alzheimer's disease

Also Published As

Publication number Publication date
JP4430306B2 (en) 2010-03-10
GB0106051D0 (en) 2001-05-02
AU2002238766A1 (en) 2002-09-24
US20040132113A1 (en) 2004-07-08
DE60216570T2 (en) 2007-04-05
JP2010166922A (en) 2010-08-05
ES2272673T3 (en) 2007-05-01
WO2002073212A2 (en) 2002-09-19
EP1370870B9 (en) 2009-12-02
EP1724588A3 (en) 2007-09-05
ATE347698T1 (en) 2006-12-15
EP1370870B1 (en) 2006-12-06
EP1370870A2 (en) 2003-12-17
JP2008245654A (en) 2008-10-16
EP1724588B1 (en) 2017-05-03
EP1724588A2 (en) 2006-11-22
JP4541429B2 (en) 2010-09-08
JP2004531244A (en) 2004-10-14
WO2002073212A3 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
ATE526041T1 (en) METHOD FOR INHIBITING OCCULAR PROCESSES
ATE310955T1 (en) COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CHEMOKINE RECEPTOR-RELATED DISEASES
DE60224383D1 (en) PROCEDURE FOR DETECTION IN YEAST TO INFLUENCE PROTEIN FOLDING
DE60228160D1 (en) System and method for performing wireless transactions
DE60226797D1 (en) Instrument for introducing fasteners for transplants
ATE386942T1 (en) METHOD FOR PREDICTION, DIAGNOSIS AND COMPARATIVE DIAGNOSIS OF ALZHEIMER
DE60016178D1 (en) METHOD FOR DIAGNOSIS AND CHARACTERIZATION OF STROKE
ATE347698T1 (en) METHOD FOR DETECTING ALZHEIMER'S DISEASE
DE602004022124D1 (en) Method and arrangement for assessing the quality of machine translation
ATE540319T1 (en) METHOD FOR DETERMINATION OF FK506
EA200500356A1 (en) WAYS OF DETECTION OF AMNIOTIC LIQUID IN THE MOUNTING SECRET AND DEVICES FOR IMPLEMENTATION OF THE SPECIFIED METHODS
DE60328069D1 (en) Test photomask, scattered light evaluation method, and scattered light compensation method
HK1079571A1 (en) Methods for direct detection of individual methotrexate metabolites
DE60235211D1 (en) Method for pre-erasing noise of an image.
DE60322848D1 (en) SYSTEM FOR CONTINUOUS PERFORMANCE TESTS
DE60321356D1 (en) METHOD FOR DIAGNOSIS OF EGGSTOCK ENDOMETRIOSIS
DE602005026665D1 (en) ENRICHED ANTIBODY FOR THE DETECTION OF MICROBACTERIAL INFECTION, METHOD FOR THE USE AND DIAGNOSTIC TEST THEREWITH
ATE317451T1 (en) METHOD FOR DIAGNOSIS, DETECTION, AND CLASSIFICATION OF COLON CANCER
ATA1242002A (en) METHOD AND DEVICE FOR OPTICALLY TESTING SEMICONDUCTOR COMPONENTS
ATE422671T1 (en) METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE
DE60231607D1 (en) COMPOSITIONS AND METHODS FOR DETECTING EHRLICHIA CANIS AND EHRLICHIA CHAFFEENSIS ANTIBODIES
ATE393394T1 (en) METHOD FOR DETECTING PROTEINS THAT INTERACT WITH EACH OTHER
DE502004012314D1 (en) METHOD FOR THE REACTIVE-STAINING OF LEATHER, AS WELL AS DYES AND THEIR USE
DE50208871D1 (en) METHOD AND FILTRATION FOR SEPARATING CONDENSATE AND THE SIMILAR
ATE408832T1 (en) METHOD FOR DETECTING BLOOD CELL ANTIGENS AND ANTIBODIES DIRECTED AGAINST THESE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition